Gert De Hertogh Selected Research

Esophageal Neoplasms (Esophageal Cancer)

5/2018	ypT0N+: the unusual patient with pathological complete tumor response but with residual lymph node disease after neoadjuvant chemoradiation for esophageal cancer, what's up?
7/2010	Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gert De Hertogh Research Topics

Disease

33	Inflammation (Inflammations) 10/2023 - 09/2008
27	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2023 - 01/2013
25	Neoplasms (Cancer) 01/2024 - 09/2008
21	Ulcerative Colitis 05/2024 - 02/2007
20	Epiretinal Membrane (Epiretinal Membranes) 10/2023 - 01/2013
18	Crohn Disease (Crohn's Disease) 11/2023 - 04/2005
18	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2022 - 11/2009
10	Colitis 01/2021 - 09/2003
9	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 09/2008
7	Fibrosis (Cirrhosis) 12/2022 - 09/2008
6	Pouchitis 05/2024 - 01/2008
6	Hypoxia (Hypoxemia) 08/2023 - 02/2015
5	Ischemia 10/2023 - 01/2017
5	Reperfusion Injury 10/2023 - 01/2017
4	Necrosis 03/2023 - 01/2018
4	Adenocarcinoma 12/2021 - 07/2010
3	COVID-19 06/2023 - 04/2022
3	Diarrhea 06/2022 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2016 - 07/2010
2	Proliferative Vitreoretinopathy 08/2023 - 02/2018
2	Infections 06/2023 - 08/2014
2	Thrombosis (Thrombus) 03/2023 - 01/2021
2	Human Influenza (Influenza) 01/2023 - 12/2022
2	Turcot syndrome 01/2023 - 09/2013
2	Microsatellite Instability 01/2023 - 01/2020
2	Pathologic Constriction (Stenosis) 01/2022 - 09/2008
2	Intestinal Failure 01/2021 - 01/2019
2	Dyspepsia (Indigestion) 01/2021 - 10/2020
2	Failure to Thrive 05/2020 - 12/2016
2	Dysbiosis 01/2020 - 01/2018
2	Portal Hypertension 12/2018 - 11/2012
2	Esophageal Neoplasms (Esophageal Cancer) 05/2018 - 07/2010
2	Fatigue 12/2017 - 01/2016
2	Celiac Disease (Celiac Sprue) 09/2015 - 08/2015
2	Carcinoma (Carcinomatosis) 09/2014 - 07/2010
2	Granuloma 04/2012 - 02/2012

Drug/Important Bio-Agent (IBA)

17	EnzymesIBA 09/2022 - 07/2010
14	ImmunosorbentsIBA 01/2020 - 07/2010
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2010
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2010
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2010
10	Infliximab (Remicade)FDA Link 11/2019 - 02/2007
7	CytokinesIBA 08/2023 - 04/2012
7	Retinaldehyde (Retinal)IBA 08/2023 - 02/2015
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 09/2008
6	Matrix Metalloproteinases (MMPs)IBA 09/2022 - 01/2013
6	Dextrans (Dextran)FDA Link 01/2020 - 11/2016
5	vedolizumabIBA 01/2022 - 09/2017
4	Ustekinumab (CNTO 1275)FDA Link 05/2024 - 10/2019
4	LigandsIBA 10/2023 - 10/2009
4	cobaltous chloride (cobalt(II)chloride)IBA 08/2023 - 12/2016
4	Monoclonal AntibodiesIBA 08/2023 - 09/2008
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 04/2005
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 01/2017
4	Messenger RNA (mRNA)IBA 01/2018 - 10/2009
3	salicylhydroxamic acid (SHAM)IBA 10/2023 - 01/2017
3	RNA (Ribonucleic Acid)IBA 06/2023 - 01/2015
3	Oxygen (Dioxygen)IBA 01/2023 - 06/2018
3	ElectrolytesIBA 04/2022 - 12/2016
3	Hematoxylin (Haematoxylon)IBA 12/2021 - 04/2012
3	Eosine Yellowish-(YS) (Eosin)IBA 12/2021 - 04/2012
3	Drinking WaterIBA 01/2021 - 01/2018
3	Metalloproteases (Metalloproteinases)IBA 01/2020 - 02/2014
3	ChemokinesIBA 01/2020 - 07/2010
3	MicroRNAs (MicroRNA)IBA 07/2019 - 02/2012
3	Phenobarbital (Luminal)FDA Link 01/2017 - 09/2008
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017 - 12/2015
3	AntibodiesIBA 08/2015 - 08/2007
3	ErbB Receptors (EGF Receptor)IBA 06/2010 - 09/2008
2	obeticholic acidIBA 10/2023 - 01/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2022 - 02/2014
2	Peptide Hydrolases (Proteases)FDA Link 09/2022 - 12/2016
2	AcidsIBA 10/2020 - 01/2017
2	HMGB1 Protein (HMG1)IBA 10/2019 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 06/2018 - 04/2012
2	Tissue Inhibitor of Metalloproteinase-1IBA 02/2018 - 11/2016
2	Antimicrobial PeptidesIBA 01/2018 - 11/2009
2	OsteoprotegerinIBA 01/2018 - 01/2017
2	BilirubinIBA 12/2017 - 01/2016
2	SodiumIBA 01/2017 - 11/2016
2	etrolizumabIBA 02/2016 - 07/2014
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2016 - 04/2013
2	heparanaseIBA 01/2016 - 12/2015
2	Syndecan-1 (Syndecan 1)IBA 12/2015 - 01/2014
2	Cadherins (E-Cadherin)IBA 03/2015 - 04/2011
2	cadherin 5IBA 03/2015 - 02/2015
2	ThrombospondinsIBA 02/2014 - 05/2013
2	Interleukin-8 (Interleukin 8)IBA 04/2011 - 07/2010
2	Cetuximab (Erbitux)FDA Link 10/2009 - 09/2008
1	mirikizumabIBA 11/2023
1	Immune Checkpoint InhibitorsIBA 11/2023
1	InterferonsIBA 11/2023

Therapy/Procedure

25	Therapeutics 08/2023 - 04/2005
6	Restorative Proctocolectomy 05/2024 - 01/2008
5	Transplantation 01/2023 - 11/2012
4	Colectomy 01/2024 - 09/2003
4	Neoadjuvant Therapy 12/2021 - 09/2012
2	Immunotherapy 11/2023 - 01/2020
2	Esophagectomy 12/2021 - 12/2014
2	Vagus Nerve Stimulation 01/2021 - 01/2018